ClinVar Genomic variation as it relates to human health
NM_020975.6(RET):c.41_43delinsGGTTGCTGC (p.Leu13_Leu14insArgLeu)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_020975.6(RET):c.41_43delinsGGTTGCTGC (p.Leu13_Leu14insArgLeu)
Variation ID: 1737851 Accession: VCV001737851.2
- Type and length
-
Indel, 9 bp
- Location
-
Cytogenetic: 10q11.21 10: 43077299-43077301 (GRCh38) [ NCBI UCSC ] 10: 43572747-43572749 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Nov 29, 2022 May 1, 2024 Oct 29, 2020 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_020975.6:c.41_43delinsGGTTGCTGC MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_066124.1:p.Leu13_Leu14insArgLeu inframe insertion NM_000323.2:c.41_43delTGTinsGGTTGCTGC NP_000314.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406743.1:c.41_43delTGTinsGGTTGCTGC NP_001393672.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406744.1:c.41_43delTGTinsGGTTGCTGC NP_001393673.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406759.1:c.41_43delTGTinsGGTTGCTGC NP_001393688.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406760.1:c.41_43delTGTinsGGTTGCTGC NP_001393689.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406761.1:c.41_43delTGTinsGGTTGCTGC NP_001393690.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406762.1:c.41_43delTGTinsGGTTGCTGC NP_001393691.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406763.1:c.41_43delTGTinsGGTTGCTGC NP_001393692.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406764.1:c.41_43delTGTinsGGTTGCTGC NP_001393693.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406765.1:c.41_43delTGTinsGGTTGCTGC NP_001393694.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406766.1:c.41_43delTGTinsGGTTGCTGC NP_001393695.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406767.1:c.41_43delTGTinsGGTTGCTGC NP_001393696.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406768.1:c.41_43delTGTinsGGTTGCTGC NP_001393697.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406769.1:c.41_43delTGTinsGGTTGCTGC NP_001393698.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406770.1:c.41_43delTGTinsGGTTGCTGC NP_001393699.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406771.1:c.41_43delTGTinsGGTTGCTGC NP_001393700.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406772.1:c.41_43delTGTinsGGTTGCTGC NP_001393701.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406773.1:c.41_43delTGTinsGGTTGCTGC NP_001393702.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406774.1:c.41_43delTGTinsGGTTGCTGC NP_001393703.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406775.1:c.41_43delTGTinsGGTTGCTGC NP_001393704.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406776.1:c.41_43delTGTinsGGTTGCTGC NP_001393705.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406777.1:c.41_43delTGTinsGGTTGCTGC NP_001393706.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406778.1:c.41_43delTGTinsGGTTGCTGC NP_001393707.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406779.1:c.41_43delTGTinsGGTTGCTGC NP_001393708.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406780.1:c.41_43delTGTinsGGTTGCTGC NP_001393709.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406781.1:c.41_43delTGTinsGGTTGCTGC NP_001393710.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406782.1:c.41_43delTGTinsGGTTGCTGC NP_001393711.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406783.1:c.41_43delTGTinsGGTTGCTGC NP_001393712.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406784.1:c.41_43delTGTinsGGTTGCTGC NP_001393713.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406785.1:c.41_43delTGTinsGGTTGCTGC NP_001393714.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406786.1:c.41_43delTGTinsGGTTGCTGC NP_001393715.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406787.1:c.41_43delTGTinsGGTTGCTGC NP_001393716.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406788.1:c.41_43delTGTinsGGTTGCTGC NP_001393717.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406789.1:c.41_43delTGTinsGGTTGCTGC NP_001393718.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406790.1:c.41_43delTGTinsGGTTGCTGC NP_001393719.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406791.1:c.41_43delTGTinsGGTTGCTGC NP_001393720.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406792.1:c.41_43delTGTinsGGTTGCTGC NP_001393721.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406793.1:c.41_43delTGTinsGGTTGCTGC NP_001393722.1:p.Leu13_Leu14insArgLeu inframe indel NM_001406794.1:c.41_43delTGTinsGGTTGCTGC NP_001393723.1:p.Leu13_Leu14insArgLeu inframe indel NM_020629.2:c.41_43delTGTinsGGTTGCTGC NP_065680.1:p.Leu13_Leu14insArgLeu inframe indel NM_020630.7:c.41_43delTGTinsGGTTGCTGC NP_065681.1:p.Leu13_Leu14insArgLeu inframe indel NC_000010.11:g.43077299_43077301delinsGGTTGCTGC NC_000010.10:g.43572747_43572749delinsGGTTGCTGC NG_007489.1:g.5231_5233delinsGGTTGCTGC NG_045003.1:g.4486_4488delinsGGTTGCTGC LRG_518:g.5231_5233delinsGGTTGCTGC LRG_518t1:c.41_43delTGTinsGGTTGCTGC LRG_518p1:p.Leu13_Leu14insArgLeu LRG_518t2:c.41_43delTGTinsGGTTGCTGC LRG_518p2:p.Leu13_Leu14insArgLeu - Protein change
- -
- Other names
- -
- Canonical SPDI
- NC_000010.11:43077298:TGT:GGTTGCTGC
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
RET | Sufficient evidence for dosage pathogenicity | No evidence available |
GRCh38 GRCh37 |
3598 | 3720 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Uncertain significance (1) |
criteria provided, single submitter
|
Oct 29, 2020 | RCV002323341.2 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Uncertain significance
(Oct 29, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary cancer-predisposing syndrome
Affected status: unknown
Allele origin:
germline
|
Ambry Genetics
Accession: SCV002632380.2
First in ClinVar: Nov 29, 2022 Last updated: May 01, 2024 |
Comment:
The c.41_43delTGTinsGGTTGCTGC variant (also known as p.R12_L13dup), located in coding exon 1 of the RET gene, results from an in-frame deletion of TGT and insertion … (more)
The c.41_43delTGTinsGGTTGCTGC variant (also known as p.R12_L13dup), located in coding exon 1 of the RET gene, results from an in-frame deletion of TGT and insertion of GGTTGCTGC at nucleotide positions 41 to 43. This results in the duplication of two residues (RL) at codon 12. This amino acid region is highly conserved on limited sequence alignment. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. (less)
|
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpThere are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated May 01, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.